Aktienanalyse zu SS Innovations International Inc (SSII)SSIISS Innovations International Inc

SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset. It operates in the Healthcare sector.

Currently, SS Innovations International Inc (SSII) is not a good buy. The stock is trading at $2.53, which is significantly below its analyst price target of $7, indicating potential upside. However, the stock has shown a year-to-date change of -55.22% and a one-year change of -74.65%, reflecting substantial losses. Additionally, the RSI is at 31.583, suggesting the stock is oversold but also indicating a lack of momentum for recovery. The main risk is the company's negative net income, which was -2,661,350 USD in Q2 2026, highlighting ongoing financial struggles.